# Selective Safety Data Collection: When "Less" Is Better

Page: https://stenobird.com/podcast/decentralized-the-decentralized-trials-research-podcast-6281264/selective-safety-data-collection-when-less-is-better
Text version: https://stenobird.com/podcast/decentralized-the-decentralized-trials-research-podcast-6281264/selective-safety-data-collection-when-less-is-better.md
Podcast: [Decentralized: The Decentralized Trials & Research Podcast](https://stenobird.com/podcast/decentralized-the-decentralized-trials-research-podcast-6281264)
Published: 2026-02-23T13:00:00+00:00
Episode link: https://www.dtra.org
Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/ffb2a457-c9da-4f03-a555-ef6b3ff9aa28.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/decentralized-the-decentralized-trials-research-podcast-6281264/episodes/selective-safety-data-collection-when-less-is-better
Duration seconds: 3471

## Resource

2026-02-20 Hosts Craig Lipset, Dr. Amir Kalali, and Jane Myles were joined my Meghana Chalaseni, Mary Thanh-Hai, and Mitch Psotka from the FDA. Today’s session focused on Selective Safety Data Collection (SSDC) and how it can streamline clinical trials when a drug’s safety profile is already well-established. Mary Thanh Hai and Mitch Psotka explained that SSDC, formalized through FDA guidance and ICH E19, allows for a planned reduction in low-value safety data while maintaining robust monitoring of serious adverse events and other critical outcomes. The panel addressed common misconceptions, emphasizing that SSDC does not lower safety standards or eliminate oversight, it simply focuses on collecting data that meaningfully informs the risk-benefit profile. Meghana Chalasani also highlighted FDA’s C3TI demonstration program and other innovative approaches like Bayesian methods and streamlined trials embedded in clinical practice. The discussion closed with practical site-level considerations, including how to integrate SSDC into existing workflows while maintaining consistency and regulatory alignment. Overall, the conversation underscored a shift toward smarter, more efficient trial design without compromising patient safety. You can join TGIF-DTRA Sessions live on LinkedIn Live on Friday's at 12:00 PM ET by checking out our LinkedIn. Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and X . Learn more about Membership options and our work at www.dtra.org .

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/decentralized-the-decentralized-trials-research-podcast-6281264/episodes/selective-safety-data-collection-when-less-is-better/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/decentralized-the-decentralized-trials-research-podcast-6281264/selective-safety-data-collection-when-less-is-better.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.